Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Wave Life Sciences Ltd.’s stock clocked out at $5.12, down -7.75% from its previous closing price of $5.55. In other words, the price has decreased by -$7.75 from its previous closing price. On the day, 0.83 million shares were traded. WVE stock price reached its highest trading level at $5.55 during the session, while it also had its lowest trading level at $5.065.
Ratios:
To gain a deeper understanding of WVE’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.99 and its Current Ratio is at 0.99. In the meantime, Its Debt-to-Equity ratio is 6.56 whereas as Long-Term Debt/Eq ratio is at 4.93.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wells Fargo on May 15, 2024, initiated with a Overweight rating and assigned the stock a target price of $11.
On December 19, 2023, Leerink Partners Upgraded its rating to Outperform which previously was Market Perform and also upped its target price recommendation from $5 to $12.
On July 05, 2023, Raymond James started tracking the stock assigning a Outperform rating and target price of $7.Raymond James initiated its Outperform rating on July 05, 2023, with a $7 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Aug 21 ’24 when BOLNO PAUL sold 48,366 shares for $5.78 per share. The transaction valued at 279,555 led to the insider holds 359,059 shares of the business.
PAUL BOLNO bought 48,366 shares of WVE for $279,638 on Aug 21 ’24. On Apr 03 ’24, another insider, Moran Kyle, who serves as the Chief Financial Officer of the company, sold 15,630 shares for $6.17 each. As a result, the insider received 96,421 and left with 33,921 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, WVE now has a Market Capitalization of 638658560 and an Enterprise Value of 575086144. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.78. Its current Enterprise Value per Revenue stands at 5.204 whereas that against EBITDA is -7.245.
Stock Price History:
Over the past 52 weeks, WVE has reached a high of $7.67, while it has fallen to a 52-week low of $3.50. The 50-Day Moving Average of the stock is -10.50%, while the 200-Day Moving Average is calculated to be -5.66%.
Shares Statistics:
It appears that WVE traded 869.24K shares on average per day over the past three months and 442720 shares per day over the past ten days. A total of 119.16M shares are outstanding, with a floating share count of 98.27M. Insiders hold about 21.22% of the company’s shares, while institutions hold 75.30% stake in the company. Shares short for WVE as of 1723680000 were 3349379 with a Short Ratio of 3.85, compared to 1721001600 on 3884745. Therefore, it implies a Short% of Shares Outstanding of 3349379 and a Short% of Float of 5.510000000000001.
